首页 › 基金 › C WorldWide Group Holding A/S › NVCR

C WorldWide Group Holding A/S 对 NVCR 的持仓历史

NOVOCURE LTD · 医疗保健

C WorldWide Group Holding A/S 在 Q3 2026 的 13F 申报中披露持有 NVCR(NOVOCURE LTD)971,784 股,市值约 US$15.5M,约占其申报组合的 0.39%,在其申报持仓中市值排名第 41 位。 C WorldWide Group Holding A/S 最近 13 个申报季度中有 13 个季度披露了 NVCR 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)971.78K 股
申报持仓市值$15.50M
组合权重0.39%
首次申报Q3 2023
最近变动持有
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

C WorldWide Group Holding A/S 对 NVCR 的持仓演变

C WorldWide Group Holding A/S 于 Q3 2023 首次披露 NVCR 持仓:221,784 股(约 US$3.6M)。 该持仓在 Q4 2024 达到峰值 621,784 股,市值约 US$18.5M。 在 13 次申报中,C WorldWide Group Holding A/S 3 次增持、0 次减持、9 次保持不变。 最近一期申报(Q3 2026)显示持股 971,784 股、市值约 US$15.5M。 持仓曾出现大幅变动:Q4 2023 增持约 135% (随后一个季度股价上涨 5%)、Q3 2025 增持约 56% (随后一个季度股价基本持平)。

逐季持仓明细

季度股数金额变化
Q3 2023 221.78K $3.58M 新进
Q4 2023 521.78K $7.79M 增持
Q1 2024 521.78K $8.15M 持有
Q2 2024 521.78K $8.94M 持有
Q3 2024 521.78K $8.15M 持有
Q4 2024 621.78K $18.53M 增持
Q1 2025 621.78K $11.08M 持有
Q2 2025 621.78K $11.07M 持有
Q3 2025 971.78K $12.55M 增持
Q4 2025 971.78K $12.56M 持有
Q1 2026 971.78K $10.59M 持有
Q2 2026 971.78K $14.72M 持有
Q3 2026 971.78K $15.50M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 NVCR 与 13F 数据

NVCR(NOVOCURE LTD)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 NVCR,申报仓位最大的包括:Soleus Capital Management, L.P. (US$150.2M), Palo Alto Investors LP (US$19.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 NVCR 的基金

查看 NVCR 的全部基金持有人 →

常见问题

How long has C WorldWide Group Holding A/S held NVCR?

C WorldWide Group Holding A/S has disclosed NVCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is C WorldWide Group Holding A/S's current position in NVCR?

As of Q3 2026, C WorldWide Group Holding A/S holds 971.78K shares of NVCR (NOVOCURE LTD), valued at $15.50M, representing 0.39% of its reported portfolio and ranking #41.

Has C WorldWide Group Holding A/S been buying or selling NVCR?

In the latest 13F filing (Q3 2026), C WorldWide Group Holding A/S held unchanged its position in NVCR. The position peaked in Q4 2024 at 621.78K shares.

Which other funds hold NVCR?

Other major institutional holders of NVCR include Soleus Capital Management, L.P., Palo Alto Investors LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.